PUMA BIOTECHNOLOGY, INC. Common Stock Shares Outstanding

Quick Answer

PUMA BIOTECHNOLOGY, INC. reported Common Stock Shares Outstanding of 50.41 million shares for the year ending 2025.

  • PUMA BIOTECHNOLOGY, INC. showed an increase of +2.7% in Common Stock Shares Outstanding from 2024 to 2025.
  • This data is from PUMA BIOTECHNOLOGY, INC.'s annual report (Form 10-K), filed with the SEC on February 26, 2026.
  • XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 16 years of available data (2010 to 2025), PUMA BIOTECHNOLOGY, INC.'s Common Stock Shares Outstanding has grown by 1,160.2%.
  • Historical annual values: Fiscal year 2025: 50.41 million shares | Fiscal year 2024: 49.11 million shares | Fiscal year 2023: 47.65 million shares | Fiscal year 2022: 46.35 million shares | Fiscal year 2021: 41.18 million shares | Fiscal year 2020: 40.09 million shares | Fiscal year 2019: 39.20 million shares | Fiscal year 2018: 38.33 million shares | Fiscal year 2017: 37.59 million shares | Fiscal year 2016: 36.83 million shares | Fiscal year 2015: 32.47 million shares | Fiscal year 2014: 30.55 million shares | Fiscal year 2013: 28.99 million shares | Fiscal year 2012: 28.68 million shares | Fiscal year 2011: 20.04 million shares | Fiscal year 2010: 4.00 million shares.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: